JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
51 hedge funds and large institutions have $42.2M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
Holders
51
Holding in Top 10
–
Calls
$1.56M
Puts
$421K
Top Buyers
| 1 | +$2.96M | |
| 2 | +$1.72M | |
| 3 | +$1.26M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.18M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.04M |
Top Sellers
| 1 | -$933K | |
| 2 | -$886K | |
| 3 | -$759K | |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$750K |
| 5 |
BAMS
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
|
-$707K |